As an endogenous neuroprotective kinase, PAK4 and the PAK4-CRTC1S215-CREB pathway may be useful therapeutic targets for alleviating the symptoms of Parkinson’s disease (Won et al., 2016). Here, PAK4 is linked to Parkinson disease.